Jim Marucci, neurovascular president of Stryker, discusses the company's advancements in neurovascular technology, including the recent acquisition of Cerus Endovascular. They explore the development of the Target Tetra detachable coil and the potential of AI/AR in neurovascular procedures. The conversation highlights Stryker's commitment to enhancing stroke care and improving access to neurovascular treatments globally.